drugset / Trial / NCT07136142
A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This study aims to evaluate the safety, tolerability, pharmacokinetics and immunogenicity of FH-006 in subjects with advanced malignant solid tumors, and determine the preliminary efficacy.
Timeline
- Start
- 2025-09-23
- Primary completion
- 2027-02
- Completion
- 2027-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FH-006 | Unknown | — | — |
| Background | Adebrelimab | Monoclonal antibody | — | — |
| Background | Paclitaxel | Small molecule | — | — |